Thomas Von Koch - 08 Jul 2022 Form 4 Insider Report for DiaMedica Therapeutics Inc. (DMAC)

Role
10%+ Owner
Signature
/s/ Thomas Von Koch
Issuer symbol
DMAC
Transactions as of
08 Jul 2022
Net transactions value
+$275,898
Form type
4
Filing time
21 Jul 2022, 13:06:40 UTC
Next filing
06 Dec 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DMAC Common Shares Purchase $275,898 +207,974 +7.9% $1.33 2,855,827 08 Jul 2022 See Footnote F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.3025 to $1.355, inclusive. The reporting person undertakes to provide to DiaMedica Therapeutics Inc., any security holder of DiaMedica Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
F2 These shares are owned directly by TomEnterprise AB and indirectly by Thomas Von Koch in his capacity as the board member and sole owner of TomEnterprise AB. Thomas Von Koch has the sole power to vote and dispose of these shares.